Search Results - "Tulloh, R M R"

Pulmonary arterial hypertension exacerbated by ruxolitinib by Low, Andrew T, Howard, Luke, Harrison, Claire, Tulloh, Robert M R

Get full text

Cellular and molecular basis of RV hypertrophy in congenital heart disease by Iacobazzi, D, Suleiman, M-S, Ghorbel, M, George, S J, Caputo, M, Tulloh, R M

“…RV hypertrophy (RVH) is one of the triggers of RV failure in congenital heart disease (CHD). Therefore, improving our understanding of the cellular and…”
Get more information

Kawasaki disease in children by Wood, L E, Tulloh, R M R

“…Kawasaki disease (KD) is an acute self-limiting systemic vasculitis of unknown aetiology. It is the most common cause of acquired heart disease in young…”
Get more information

Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015 by Tulloh, Robert M R, Mayon-White, Richard, Harnden, Anthony, Ramanan, Athimalaipet V, Tizard, E Jane, Shingadia, Delane, Michie, Colin A, Lynn, Richard M, Levin, Michael, Franklin, Orla D, Craggs, Pippa, Davidson, Sue, Stirzaker, Rebecca, Danson, Mike, Brogan, Paul A

“…ObjectiveKawasaki disease (KD) is an increasingly common vasculitis with risk of coronary artery aneurysms (CAAs). The last UK survey was in 1990, whereas…”
Get full text

A pilot randomised controlled trial investigating a mindfulness-based stress reduction (MBSR) intervention in individuals with pulmonary arterial hypertension (PAH): the PATHWAYS study by Tulloh, R M R, Garratt, V, Tagney, J, Turner-Cobb, J, Marques, E, Greenwood, R, Howard, L, Gin-Sing, W, Barton, A, Ewings, P, Craggs, P, Hollingworth, W

“…Pulmonary arterial hypertension (PAH) is an uncommon condition with progressive heart failure and premature death. Treatment costs up to £120,000 per patient…”
Get full text

Cardiovascular status after Kawasaki disease in the UK by Shah, V, Christov, G, Mukasa, T, Brogan, K S, Wade, A, Eleftheriou, D, Levin, M, Tulloh, R M, Almeida, B, Dillon, M J, Marek, J, Klein, N, Brogan, P A

“…Kawasaki disease (KD) is an acute vasculitis that causes coronary artery aneurysms (CAA) in young children. Previous studies have emphasised poor long-term…”
Get more information

Corticosteroids for the treatment of Kawasaki disease in children by Green, Jessica, Wardle, Andrew J, Tulloh, Robert Mr

“…Kawasaki disease (KD), or mucocutaneous syndrome, is the leading cause of childhood-acquired heart disease in high-income countries. There is much controversy…”
Get more information

Paediatric pulmonary hypertension and sildenafil: current practice and controversies by Wardle, A J, Tulloh, R M R

“…In recent times, paediatric pulmonary arterial hypertension management has been transformed to focus on disease modifying strategies that improve both quality…”
Get more information

Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United Kingdom by Constantine, Andrew, Dimopoulos, Konstantinos, Jenkins, Petra, Tulloh, Robert M R, Condliffe, Robin, Jansen, Katrijn, Chung, Natali A Y, Oliver, James, Parry, Helen, Fitzsimmons, Samantha, Walker, Niki, Wort, Stephen John, Papaioannou, Vasilios, von Klemperer, Kate, Clift, Paul

“…Background The Fontan circulation is a successful operative strategy for abolishing cyanosis and chronic volume overload in patients with congenital heart…”
Get full text

Lung Function, Inflammation, and Endothelin‐1 in Congenital Heart Disease–Associated Pulmonary Arterial Hypertension by Low, Andrew, George, Sarah, Howard, Luke, Bell, Nicholas, Millar, Ann, Tulloh, Robert M. R.

“…Background Breathlessness is the most common symptom in people with pulmonary arterial hypertension and congenital heart disease (CHD‐APAH), previously thought…”
Get full text

Adaptations of aortic and pulmonary artery flow parameters measured by phase-contrast magnetic resonance angiography during supine aerobic exercise by Pieles, Guido E., Szantho, Gergely, Rodrigues, Jonathan C. L., Lawton, Christopher B., Stuart, A. Graham, Bucciarelli-Ducci, Chiara, Turner, Mark S., Williams, Craig A., Tulloh, Robert M. R., Hamilton, Mark C. K.

“…Purpose Increased oxygen uptake and utilisation during exercise depend on adequate adaptations of systemic and pulmonary vasculature. Recent advances in…”
Get full text

Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the Week by Dimopoulos, Konstantinos, Condliffe, Robin, Tulloh, Robert M R, Clift, Paul, Alonso-Gonzalez, Rafael, Bedair, Radwa, Chung, Natali A Y, Coghlan, Gerry, Fitzsimmons, Samantha, Frigiola, Alessandra, Howard, Luke S, Jenkins, Petra, Kenny, Damien, Li, Wei, MacDonald, Simon T, McCabe, Colm, Oliver, James J, Spence, Mark S, Szantho, Gergely V, von Klemperer, Kate, Wilson, Dirk G, Wort, Stephen J

“…Echocardiography is the mainstay in screening for pulmonary hypertension (PH). International guidelines suggest echocardiographic parameters for suspecting PH,…”
Get full text

A Randomized Controlled Trial of Motavizumab Versus Palivizumab for the Prophylaxis of Serious Respiratory Syncytial Virus Disease in Children With Hemodynamically Significant Congenital Heart Disease by Feltes, Timothy F, Sondheimer, Henry M, Tulloh, Robert M R, Harris, Brian S, Jensen, Kathryn M, Losonsky, Genevieve A, Griffin, M Pamela

“…Children with hemodynamically significant congenital heart disease (CHD) are at risk for serious respiratory syncytial virus (RSV) disease. This study was…”
Get full text

Respiratory virus prophylaxis in congenital heart disease by Joshi, Manjiri, R Tulloh, Robert M

“…Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections and causes up to 200,000 infant deaths a year worldwide. The…”
Get full text

Intermittent antegrade warm-blood versus cold-blood cardioplegia in children undergoing open heart surgery: a protocol for a randomised controlled study (Thermic-3) by Heys, Rachael, Stoica, Serban, Angelini, Gianni, Beringer, Richard, Evans, Rebecca, Ghorbel, Mohamed, Lansdowne, William, Parry, Andrew, Pieles, Guido, Reeves, Barnaby, Rogers, Chris, Saxena, Rohit, Sheehan, Karen, Smith, Stella, Walker-Smith, Terrie, Tulloh, Robert MR, Caputo, Massimo

“…IntroductionSurgical repair of congenital heart defects often requires the use of cardiopulmonary bypass (CPB) and cardioplegic arrest. Cardioplegia is used…”
Get full text

Guanylate cyclase stimulators for pulmonary hypertension by Wardle, Andrew J, Seager, Matthew J, Wardle, Richard, Tulloh, Robert M R, Gibbs, J Simon R

“…Pulmonary hypertension is a condition of complex aetiology that culminates in right heart failure and early death. Soluble guanylate cyclase (sGC) stimulators…”
Get more information

Assessment of Myocardial Function in Kenyan Children With Severe, Acute Malnutrition: The Cardiac Physiology in Malnutrition (CAPMAL) Study by Brent, Bernadette, Obonyo, Nchafatso, Akech, Samuel, Shebbe, Mohammed, Mpoya, Ayub, Mturi, Neema, Berkley, James A, Tulloh, Robert M R, Maitland, Kathryn

“…Mortality among African children hospitalized with severe malnutrition remains high, with sudden, unexpected deaths leading to speculation about potential…”
Get full text

The incidence of Kawasaki disease after vaccination within the UK pre-school National Immunisation Programme: an observational THIN database study by Hall, Gillian C, Tulloh, Robert MR, Tulloh, Louise E

“…Purpose To provide expected incidence rates of Kawasaki disease after vaccination in routine clinical practice and as recommended within a pre‐school National…”
Get full text

Lung function in pulmonary hypertension by Low, A.T, Medford, A.R.L, Millar, A.B, Tulloh, R.M.R

“…Abstract Breathlessness is a common symptom in pulmonary hypertension (PH) and an important cause of morbidity. Though this has been attributed to the well…”
Get full text

Does Maintenance of Pulmonary Blood Flow Pulsatility at the Time of the Fontan Operation Improve Hemodynamic Outcome in Functionally Univentricular Hearts? by Kalia, K., Walker-Smith, P., Ordoñez, M. V., Barlatay, F. G., Chen, Q., Weaver, H., Caputo, M., Stoica, S., Parry, A., Tulloh, R. M. R.

“…It is unclear whether residual anterograde pulmonary blood flow (APBF) at the time of Fontan is beneficial. Pulsatile pulmonary flow may be important in…”
Get full text